Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma
about
Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.IκB kinase b Mediating the Downregulation of p53 and p21 by Lipopolysaccharide in Human Papillomavirus 16+ Cervical Cancer Cells.Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-κB pathway.Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
P2860
Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibitors of NF-kappaB revers ...... e oral squamous cell carcinoma
@en
Inhibitors of NF-kappaB revers ...... oral squamous cell carcinoma.
@nl
type
label
Inhibitors of NF-kappaB revers ...... e oral squamous cell carcinoma
@en
Inhibitors of NF-kappaB revers ...... oral squamous cell carcinoma.
@nl
prefLabel
Inhibitors of NF-kappaB revers ...... e oral squamous cell carcinoma
@en
Inhibitors of NF-kappaB revers ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Inhibitors of NF-kappaB revers ...... e oral squamous cell carcinoma
@en
P2093
Jeff Johnson
M Sharon Stack
Yueying Liu
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2014.02.004
P407
P50
P577
2014-02-28T00:00:00Z